Pharmacodynamics of Moxifloxacin against Streptococcus pyogenes in an In Vitro Kinetic Model

The aim of the present study was to investigate the pharmacodynamics of moxifloxacin against strains of Streptococcus pyogenes with different susceptibilities to erythromycin by using an in vitro kinetic model simulating human pharmacokinetics of moxifloxacin at oral doses of 400 and 200 mg, respect...

Täydet tiedot

Bibliografiset tiedot

Julkaisussa:	Antimicrob Agents Chemother
Päätekijät:	Odenholt, Inga, Löwdin, Elisabeth, Gustafsson, Ingegerd, Cars, Otto
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	American Society for Microbiology (ASM) 2002
Aiheet:	Experimental Therapeutics
Linkit:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC127214/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12019138/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.46.6.2046-2048.2002
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!